INS and type 1 diabetes mellitus: The crucial importance of intervening at the right time has been brought a step further with the pre-POINT trial, which ultimately aimed at assessing the efficacy of orally administrated insulin to prevent or delay T1D onset in aAb-negative, genetically at-risk children [23].